首页 > 市场调查报告书 > 医疗设备

手术用器具泌尿科

市场调查报告书

商品编码

1374803

全球碎石设备市场 -2023-2030

Global Lithotripsy Devices Market -2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

碎石设备是泌尿科和肾臟科用于进行碎石术的医疗设备或机器，碎石术是一种非侵入性医疗程序，旨在分解和破碎泌尿道不同区域（例如肾臟、输尿管或肾臟）中形成的结石或结石。膀胱。

碎石设备是研究和培训环境中的重要设备，用于检查碎石技术并对医疗保健专业人员进行使用教育，强调其在改善患者护理和医疗实践方面的多功能性。

近年来，由于技术进步以及尿路结石和其他泌尿道疾病病例的增加，碎石设备市场显着成长。

市场动态：驱动因素与限制因素

碎石设备的不断进步

由于持续的技术改进，预计碎石设备市场将推动市场发展。这些发展正在改变泌尿外科和肾臟病学领域，提高碎石手术的有效性和安全性，并推动市场成长。

例如，2022 年 2 月，Applaud Medical 的声学增强器技术获得了 FDA 的突破性装置头衔。这项创新旨在与输尿管镜雷射碎石术 (URS-LL) 结合使用，以分解尺寸从 6 毫米到 20 毫米的钙基肾结石。声学增强器是一个充满气体的小气泡，并被专门为此目的设计的脂质壳覆盖。

此外，2021年2月，美国食品药物管理局（FDA）批准了衝击波血管内碎石（IVL）系统用于治疗高度钙化的冠状动脉斑块。该装置使用球囊提供能够穿过软动脉组织的声压波，主要目的是选择性地分解钙化斑块以改善支架插入。

此外，尿路结石和泌尿道疾病的盛行率不断增加以及人口老化是预计在预测期内推动全球碎石设备市场的其他主要因素。

市场动态：克制

碎石设备的高成本是该市场的主要限制，特别是在医疗保险机会有限的发展中国家。例如，根据澳洲健康与福利研究所 2023 年的文章，胆管结石碎石术的平均费用可能在 2,100-3,300 美元之间。

此外，与碎石手术相关的副作用和併发症导致疼痛、瘀伤和肾损伤的风险，以及取石替代疗法的可用性是在预测期内抑制市场的因素。

For instance, in February 2022, Applaud Medical obtained a Breakthrough Device Designation from the FDA for its Acoustic Enhancer technology. This innovation is intended to be used in combination with ureteroscopy with laser lithotripsy (URS-LL) to break down calcium-based kidney stones ranging in size from 6 mm to 20 mm. The Acoustic Enhancer is a small bubble filled with gas and covered by a lipid shell that has been specially designed for this purpose.

Furthermore, in February 2021, The US Food and Drug Administration (FDA) has approved the Shockwave intravascular lithotripsy (IVL) system for the treatment of highly calcified coronary arterial plaques. This device uses a balloon to provide sonic pressure waves capable of passing through soft artery tissue, with the main objective of selectively breaking down calcified plaque to improve stent insertion.

Furthermore, the increasing prevalence of urolithiasis and urinary tract disorders and aging population are some of the other major factors that are expected to drive the global lithotripsy devices market over the forecast period.

Market Dynamics: Restraint

The high cost associated with the lithotripsy devices is major restraint for this market, especially in developing countries with limited access to healthcare insurance. For instance, according to Australian Institute of Health and Welfare 2023 article, the average cost of lithotripsy of bile duct stones may range within $2,100-3,300.

Furthermore, the side effects and complications associated with the lithotripsy procedures causing pain, bruising, and the risk of renal injury and and the availability of alternative treatments for stone removal are the factors that will restrain the market over the forecast period.

Segment Analysis

The global lithotripsy devices is segmented based on type, application, end user and region.

The extracorporeal shock wave lithotripsy devices segment accounted for approximately 54.2 % of the market share

The extracorporeal shock wave lithotripsy devices segment accounted for 54.2% and it is expected to be dominated during the forecast period. Extracorporeal shock wave lithotripsy is a technique that uses a lithotripter to produce a series of shock waves to break up stones in the urinary system, bile ducts, or pancreatic ducts. The segment is expected to drive owing to the increasing centers for lithotripsy and rising prevalence of kidney stones where extracorporeal shock wave lithotripsy devices play a major role.

For instance, in May 2023, the Government Kilpauk Medical College (KMC) Hospital launched an extracorporeal shock wave lithotripsy (ESWL) Treatment Center. MOBIS India Foundation financed the ESWL machine, which costs 2.3 crore, as part of its corporate social responsibility funding.

Furthermore, the rising prevalence of kidney stones is major driving factors for this segment. For instance, according to National Kidney Foundation article, approximately one in ten people is expected to have kidney stone at some stage of their life. Moreover, more than one million people go the emergency rooms for kidney stone every year. Thus, owing to the above factors the segment is expected to dominate over the forecast period.

Geographical Analysis

North America accounted for approximately 37.4% of the market share in 2022

North America is estimated to hold about 37.4% of the total market share throughout the forecast period, owing to the increasing number of investment, increasing prevalence of kidney disease, product approvals, rising geriatric population, collaboration with the key players, and others that will drive this region further during the forecast period.

For instance, Adventist Health Hanford invested about USD 250,000 in November 2022 to acquire the Lumenis Pulse 120H Holmium Laser System with MOSES Technology. This cutting-edge device not only allows for speedier surgeries, saving up to 20% of the time, but it also decreases anesthetic usage, promotes faster patient recovery, and allows for outpatient treatment without hospitalization.

Furthermore, according to the Centers for Disease Control and Prevention, around 37 million people, or one in every seven adults or 15% of the adult population, were expected to have chronic renal disease by July 2022. As the prevalence of kidney disease rises, more than 50,000 lithotripsy treatments are conducted in the U.S. each year, contributing to the growth of the lithotripsy device market over the forecast period.

COVID-19 Impact Analysis

The lithotripsy device market is expected to face a setback as a result of the COVID-19 outbreak. When the pandemic occurred, the growth of the lithotripsy device industry halted. Surgical operations and non-urgent medical treatments unrelated to COVID-19 were placed on hold or canceled for the time being.

For instance, Kidney Care UK provided data in March 2021 indicating that the National Health Service (NHS) disrupted the care of more than 56% of patients. Furthermore, the report indicated that more than 28% of patients were waiting for procedures and were unable to acquire basic appointments. Furthermore, more than 18% of patients experienced difficulty reaching their general practitioners or hospital teams for medical consultations, and more than 7% reported worsening health as a result of delayed care. However, the market is expected to be stable and grow over the period of time as the resumption of all services occurs.

Competitive Landscape

The major global players in the lithotripsy devices market include: Olympus Corporation, Boston Scientific Corporation, NOVAMEDTEK, Inceler Medikal Co. Ltd., EDAP TMS, Advin Health Care, MTS Medical, STORZ MEDICAL AG, Shenzhen Huikang Medical Apparatus Co., Ltd., Medispec and among others.

Key Developments

In May 2, 2023, the Government Kilpauk Medical College (KMC) Hospital launched an extracorporeal shock wave lithotripsy (ESWL) Treatment Center. MOBIS India Foundation financed the ESWL machine, which costs 2.3 crore, as part of its corporate social responsibility funding.
In March 31, 2022, Shockwave Medical, Inc., a pioneer in the advancement of Intravascular Lithotripsy (IVL) for treating severely calcified cardiovascular disease, announced the global commercial availability of the Shockwave M5 + peripheral IVL catheter following CE Mark and FDA clearance. The Shockwave M5 + catheter, which has only recently been available, is specifically developed to reduce IVL treatment time, provide alternate access options, and expand IVL therapy to patients with larger vessel diameters.

Why Purchase the Report?

To visualize the global lithotripsy devices market segmentation-based on type, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of lithotripsy devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global lithotripsy market report would provide approximately 77 tables, 77 figures, and 185 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Driver
  - 4.1.1.1. The continuous advancements in lithotripsy devices
- 4.1.2. Restraints
  - 4.1.2.1. The high cost associated with the lithotripsy devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Extracorporeal Shock Wave Lithotripsy Devices*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Intracorporeal Lithotripsy Devices

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Kidney Stones*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ureteral Stones
8.4. Pancreatic Stones
8.5. Bile Duct Stones

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Specialty Clinics
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Olympus Corporation*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Boston Scientific Corporation
12.3. NOVAMEDTEK
12.4. Inceler Medikal Co. Ltd.
12.5. EDAP TMS
12.6. Advin Health Care
12.7. MTS Medical
12.8. STORZ MEDICAL AG
12.9. Shenzhen Huikang Medical Apparatus Co., Ltd.
12.10. Medispec

LIST NOT EXHAUSTIVE